EUVIMEDEUVIMED entdecken
Crossref

Antimicrobial Resistance Patterns of Clinical Helicobacter pylori Isolates From Gastric Cancer Patients

Yupei Zhang, Kai Liu iD, Xiaona Song, Yalin Shen, Alfred Tay iD, Barry J Marshall, Hong Tang, Hong Li iD

The Journal of Infectious Diseases · 2025

DOI: 10.1093/infdis/jiaf400 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2025. Verfasst von Yupei Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center of Infectious Diseases, West China Hospital of Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, Helicobacter pylori, Helicobacter Infections, Anti-Bacterial Agents. Die Arbeit nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The increasing antibiotic resistance of Helicobacter pylori poses challenges in selecting effective eradication therapies for patients with gastric cancer. This study aimed to assess the antibiotic resistance patterns of clinical H. pylori strains isolated from gastric cancer patients, to guide H. pylori eradication strategies for those with residual gastric mucosa after gastrectomy.

Methods

This study enrolled 115 consecutive patients with gastric cancer who had a positive 13C urea breath test, all of whom were scheduled for gastric resection at West China Hospital of Sichuan University. Gastric mucosa samples were collected for pathological examination, H. pylori culture, and susceptibility testing using E-test and disk diffusion methods.

Results

From 115 specimens, 86 H. pylori strains were cultured (74.8% culture rate). Of the 86 patients (59 males, 27 females; median age 59, range 34–79) with successful H. pylori isolation, histopathology revealed 37 intestinal-type, 27 diffuse-type, 9 mixed-type, and 13 unclassified gastric cancers. Sixty-one patients underwent distal gastrectomy, and 25 had radical total gastrectomy. Notably, 12 patients were diagnosed at ≤45 years, including 9 females, all with signet ring cell carcinoma. Antibiotic resistance rates were rifampicin (RIF) (69.8%), metronidazole (MTZ) (75.6%), clarithromycin (CLR) (41.9%), levofloxacin (LEV) (32.6%), amoxicillin (AML) (2.3%), tetracycline (TET) (1.2%), and furazolidone (FZD) (0%).

Conclusions

H. pylori isolates from gastric cancer patients exhibited high resistance to RIF, MTZ, CLR, and LEV, but negligible resistance to AML, FZD, and TET. Given the compromised health status and need for concurrent therapies in these patients, AML- and/or minocycline-based regimens may represent a practical and effective treatment option for H. pylori eradication in gastric cancer patients with residual gastric mucosa after distal gastrectomy, to reduce the risk of metachronous gastric cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsHelicobacter pyloriHelicobacter InfectionsAnti-Bacterial AgentsDrug Resistance, BacterialHumansMaleFemaleMiddle AgedAgedAdultMicrobial Sensitivity TestsGastrectomyChinaGastric Mucosa

Stichwörter der Autor:innen

Helicobacter pyloriantimicrobial susceptibility testingeradication therapygastric cancer

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Center of Infectious Diseases, West China Hospital of Sichuan University, Chengdu, China.
  • Laboratory of Infectious and Liver Diseases, Institute of Infectious Diseases, West China Hospital of Sichuan University, Chengdu, China.
  • Department of General Surgery and Laboratory of Gastric Cancer, State Key Laboratory of Biotherapy/Collaborative Innovation Center of Biotherapy and Cancer Center, West China Hospital of Sichuan University, Chengdu, Chi…
  • Gastric Cancer Center, West China Hospital of Sichuan University, Chengdu, China.
  • Division of Infectious Diseases, State Key Laboratory of Biotherapy and Center of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, China.
  • Helicobacter pylori Research Laboratory, Marshall Centre for Infectious Diseases Research and Training, School of Biomedical Sciences, University of Western Australia, Perth, Australia.

ORCID-Profile: Kai Liu, Alfred Tay, Hong Li

Zitieren

APA

Zhang, Y., Liu, K., Song, X., Shen, Y., Tay, A., Marshall, B. J., Tang, H., & Li, H. (2025). Antimicrobial Resistance Patterns of Clinical Helicobacter pylori Isolates From Gastric Cancer Patients. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiaf400

Vancouver

Zhang Y, Liu K, Song X, Shen Y, Tay A, Marshall BJ, et al. Antimicrobial Resistance Patterns of Clinical Helicobacter pylori Isolates From Gastric Cancer Patients. The Journal of Infectious Diseases. 2025. doi:10.1093/infdis/jiaf400

BibTeX
@article{Zhang2025,
  author = {Zhang, Yupei and Liu, Kai and Song, Xiaona and Shen, Yalin and Tay, Alfred and Marshall, Barry J and Tang, Hong and Li, Hong},
  title = {Antimicrobial Resistance Patterns of Clinical Helicobacter pylori Isolates From Gastric Cancer Patients},
  journal = {The Journal of Infectious Diseases},
  year = {2025},
  doi = {10.1093/infdis/jiaf400}
}
Kostenlos starten →